Ledger.Open graph →
SEC Form D · filed May 12, 2021

NeuImmune, Inc

Offering
$105K
Sold
$105K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SYKESVILLE, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Thomas R. Fuerst · SYKESVILLE, MDExec · DirectorKenneth C. Carter · SYKESVILLE, MDDirectorEdward Gelsthorpe · London, United KingdomExec · DirectorSanjay Goel · CAMBRIDGE, MADirectorNeeraj K. Malhotra · Quatre Bornes, O4Exec · DirectorHilal D. Tabsh · Long Beach, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗